Literature DB >> 7208527

Development of a bioassay for ovarian carcinoma colony-forming cells.

A W Hamburger, S E Salmon, D S Alberts.   

Abstract

We have reviewed the application of our in vitro assay for human tumor stem cells to the cloning of human ovarian adenocarcinoma cells in soft agar. Tumor colonies grew from both effusions and biopsies from 85% of more than 100 ovarian cancer patients tested. Up to 2,000 colonies appeared after 10 to 14 days in culture, yielding a maximum plating efficiency of 1%. Cells from nonmalignant effusions did not form colonies under these conditions. The number of tumor colonies was proportional to the number of cells plated between concentrations of 104 to 106 cells/dish. Morphological and histochemical criteria showed that the colonies consisted of cells with the same characteristics as those of the original tumor. H3Tdr suicide colony-forming cells were actively in transient through the cell cycle. Removal of phagocytic cells with carbonyl iron markedly reduced the plating efficiency, and 2-mercaptoethanol could only partially substitute for macrophages. Spleen cell-conditioned medium from oil-primed BALB/c mice was not required. Endogenous macrophages within the tumor may provide the conditioning factor or factors required for in vitro growth. Thus, this assay is proving extremely useful for studying the biology and drug sensitivity of human ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7208527

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  4 in total

1.  Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.

Authors:  D S Alberts; S E Salmon; H S Chen; T E Moon; L Young; E A Surwit
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

2.  Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia.

Authors:  C U Ludwig; Y M Peng; J N Beaudry; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets.

Authors:  Jorge Yassen Díaz-Blancas; Ismael Dominguez-Rosado; Carlos Chan-Nuñez; Jorge Melendez-Zajgla; Vilma Maldonado
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

4.  KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.

Authors:  Nibedita Chattopadhyay; Allison J Berger; Erik Koenig; Bret Bannerman; James Garnsey; Hugues Bernard; Paul Hales; Angel Maldonado Lopez; Yu Yang; Jill Donelan; Kristen Jordan; Stephen Tirrell; Bradley Stringer; Cindy Xia; Greg Hather; Katherine Galvin; Mark Manfredi; Nelson Rhodes; Ben Amidon
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.